Ubiquitous Aspirin: A Systematic Review of Its Impact on Sensorineural Hearing Loss
- 30 October 2014
- journal article
- review article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 152 (1) , 23-41
Abstract
Objective: This systematic review evaluates the impact of aspirin on audiometric outcomes with respect to: (1) doses exceeding 325 mg daily, (2) doses of 325 mg daily or less, (3) studies applicable to the general populace, and (4) studies applicable to those with inflammatory conditions. It also assesses the impact of aspirin on (a) self‐reported hearing loss, (b) noise‐induced audiometric changes, and (c) the adverse otological effects of aminoglycoside therapy.Data Sources: Computerized searches of MEDLINE, PubMed, Cochrane, and EMBASE databases were performed, updated through January 2014, and supplemented by manual searches and inquiries to topic experts.Review Methods: A systematic review was performed according to an a priori protocol. Data extraction was performed by 2 independent parties and focused on relevant audiological measurements, potential confounders, and study design elements associated with risk of bias, including utilization of randomization, prospective/retrospective data collection, and incorporation of blinding.Results: The 37 criterion‐meeting studies included a combined total of 185,155 participants. Aspirin ingestion ≥1.95 g/d was associated with worse audiometric results (4‐112 dB threshold shift); the effect was dose dependent and reversible in the short term. There were no audiometric data that confirm that long‐term doses of 81 mg or 325 mg daily have no hearing consequences. Paradoxically, aspirin (in doses shown to be detrimental in isolation) had a protective effect when co‐administered with intravenous gentamicin.Conclusions: With the large‐scale population utilization of aspirin for cardiovascular prophylaxis, the potential risks to hearing health should be considered for future longitudinal study, particularly given that short‐term effects may be reversible.Keywords
This publication has 74 references indexed in Scilit:
- Hearing Loss in Older AdultsJAMA, 2012
- Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological researchJournal of Evaluation in Clinical Practice, 2012
- Hearing Loss Prevalence in the United StatesArchives of internal medicine (1960), 2011
- Hearing Sensitivity in Older Adults: Associations with Cardiovascular Risk Factors in the Health, Aging and Body Composition StudyJournal of the American Geriatrics Society, 2011
- Systematic review and meta-analysis methodologyBlood, 2010
- Analgesic Use and the Risk of Hearing Loss in MenThe American Journal of Medicine, 2010
- The role of PKCζ in amikacin-induced apoptosis in the cochlea: Prevention by aspirinApoptosis, 2007
- Clinical Practice Guidelines: A Manual for Developing Evidence-Based Guidelines to Facilitate Performance Measurement and Quality ImprovementOtolaryngology–Head and Neck Surgery, 2006
- Aspirin to Prevent Gentamicin-Induced Hearing LossNew England Journal of Medicine, 2006
- A Pilot Survey of Hearing Loss in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1972